Table 3.
Treatment emergent adverse events by system (n=42) reported by 14 participants
| System | # of AEs (%) |
|---|---|
| Dermatologic | 10 (24) |
| Urological | 6 (14) |
| Gastrointestinal | 4 (10) |
| Constitutional symptoms | 4 (10) |
| Ear/nose/throat | 4 (10) |
| Endocrine | 3 (7) |
| Neurological | 3 (7) |
| Infection | 2 (5) |
| Musculoskeletal | 2 (5) |
| Hematological | 2 (5) |
| Ophthalmic | 1 (2) |
| Severe respiratory | 1 (2) |